Search the Newsreel

Is It Smart To Buy Reliance, Inc. (NYSE:RS) Before It Goes Ex-Dividend?

Why (AMBA) Price Action Is Critical for Tactical Trading

This article analyzes Ambarella Inc. (NASDAQ: AMBA) for tactical trading, highlighting a strong near- and mid-term sentiment but a weak long-term outlook. It identifies key price levels, support, and resistance, and outlines three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, tailored …

Piper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)

Piper Sandler analyst Kelsey Goodwin maintained a Buy rating on Relmada Therapeutics (RLMD) with a price target of $12.00, noting Goodwin's strong track record in the Healthcare sector. H.C. Wainwright also reiterated a Buy rating and a $12.00 price target for the stock. Relmada …

Not Outback Or LongHorn — This Steakhouse Was Once Cracker Barrel's Sister Chain

This article reveals that Logan's Roadhouse, an affordable, country-themed steakhouse, was once a sister chain to Cracker Barrel. Cracker Barrel acquired Logan's Roadhouse in 1999 and sold it in 2006, having expanded the chain significantly during that period. Despite a rocky history with multiple …

Cracker Barrel’s CEO ouster surprised Wall Street but not women

Cracker Barrel's CEO, Julie Felss Masino, was unexpectedly ousted despite improving the company's financial performance and stock value after a controversial logo change. This move surprised Wall Street but not women, as female CEOs often face higher scrutiny and are more likely to be …

Relay Therapeutics (RLAY) Stock Faces Cash Burn Pressure Despite Flat Reaction

Relay Therapeutics (RLAY) saw its stock tick up slightly after Q2 2026 earnings, but the company continues to face significant cash burn pressure with a net loss of US$83.7 million and minimal revenue. Despite a recent US$300 million equity raise providing a strong cash …

Estrella Immunopharma Inc (ESLA) Stock News Today

This article provides current stock information for Estrella Immunopharma Inc (ESLA), noting its recent price of $0.723 USD, a drop of 4.01%. It mentions that news and analysis, financials, stock score, technical forecast, ownership, dividends, and profile information are available, with more news expected …

Ernest Borel Sets Board Meeting to Review 2026 Interim Results and Dividend

Perella Weinberg Partners CEO Andrew Bednar sells $4.08m in stock

Perella Weinberg Partners CEO Andrew Bednar sold approximately $4.08 million in Class A Common Stock across three transactions in early August 2026, primarily to cover tax withholding obligations on vested restricted stock units. Following these sales, Bednar directly owns over 1 million shares. This …

Dimensional Fund Advisors LP Boosts Holdings in Perella Weinberg Partners $PWP

G-III Apparel Group, LTD. (GIII) Stock Forecasts

The article "G-III Apparel Group, LTD. (GIII) Stock Forecasts" was published on Yahoo Finance but currently displays an error message, stating "Oops, something went wrong" and "Error in retrieving data." This indicates that the stock forecast content for GIII Apparel Group is not available …

Franklin Wireless Corp (FKWL) Stock News Today

This page from TradingKey provides current news and analysis for Franklin Wireless Corp (FKWL) stock. It displays the stock's market performance, including its latest price, daily change, and market capitalization. The page also offers sections for financial data, stock scores, technical forecasts, ownership details, …

3 Indian Stocks For Reliable Dividend Income When Markets Keep Shifting

Insider Selling: Perella Weinberg Partners (NASDAQ:PWP) CEO Sells 80,045 Shares of Stock

State Street (AMBA) discloses 2.56M-share, 5.8% passive stake in Ambarella

State Street Corporation has filed a Schedule 13G, disclosing a passive ownership of 2,562,733 shares, or 5.8%, of Ambarella Inc. common stock. The filing indicates shared voting and dispositive power over the majority of these shares through various affiliated investment management subsidiaries, with no …

RELX PLC (RELX) Aktuelle Aktien-News

Perella Weinberg Partners (NASDAQ: PWP) CEO sells 235,697 shares for taxes

Perella Weinberg Partners CEO, Andrew Bednar, sold 235,697 shares of Class A common stock between August 5-7, 2026. The sales, totaling approximately $4.08 million, were executed solely to cover tax withholding obligations arising from vested restricted stock units. Bednar's remaining direct holdings in Class …

Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Relay Therapeutics announced its second-quarter 2026 financial results and corporate updates, highlighting progress in its zovegalisib program for breast cancer and vascular anomalies. The company selected a triplet regimen for first-line breast cancer, with a Phase 3 trial expected in early 2027, and presented …

FMR LLC (RLAY) discloses 21.27M-share, 10% holding in Relay Therapeutics

FMR LLC has filed an amended Schedule 13G, disclosing a significant 10.0% ownership stake in Relay Therapeutics, Inc. (RLAY), totaling 21,270,751.24 shares of common stock as of July 31, 2026. The filing indicates FMR LLC holds sole voting power over 21,153,779 shares and sole …

Religare Enterprises Q1 Results: Earnings call scheduled for Aug 13

Franklin Wireless Corp (FKWL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Franklin Wireless Corp (FKWL), highlighting its current earnings forecast score of 8.00 within the Communications & Networking industry. Based on analysis from one analyst, the company has a "Buy" rating with a target price of $6.00, suggesting …

Relmada Therapeutics (NASDAQ:RLMD) Stock Price Down 6.8% - Time to Sell?

JBT Marel Corporation (NYSE:JBTM) to Issue Quarterly Dividend of $0.10

JBT Marel Corporation (NYSE:JBTM) has declared a quarterly dividend of $0.10 per share, payable on August 31st to shareholders of record as of August 17th. This dividend represents an annualized yield of 0.3%. The company recently reported quarterly EPS of $1.95, missing analyst estimates, …

JBT Marel Corporation (JBTM) stock price, news, quote and history

This article provides a comprehensive overview of JBT Marel Corporation (JBTM), including its current stock price, recent performance, key financial metrics, and analyst ratings. It highlights the company's role as a provider of technology solutions to the food and beverage industry and offers a …

Should Value Investors Buy GIII Apparel Group (GIII) Stock?

Zacks Investment Research recommends GIII Apparel Group (GIII) as a strong value stock, giving it a Zacks Rank #2 (Buy) and an "A" for Value. The company's Forward P/E ratio of 9.14 and P/S ratio of 0.52 are both lower than its industry averages, …

FMR LLC (PWP) reports 9.9M Perella Weinberg Partners shares on amended 13G

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting beneficial ownership of 9,897,190.96 shares of Perella Weinberg Partners Class A common stock, which represents 13.9% of the class. FMR LLC holds sole voting power over 9,896,595.00 shares and sole dispositive …

Kestrel Group Reports Second Quarter 2026 Financial Results

Estrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Estrella Immunopharma Inc (ESLA), detailing its current stock performance, market capitalization, and analyst ratings. It indicates a "Strong Buy" rating with a significant upside potential based on an updated analyst target price. The article also includes historical …

Tsumura (TSE:4540) Stock Cheapens As Profit Strength Meets Quality Questions

Ambarella, Inc. (NASDAQ:AMBA) Receives Average Rating of "Moderate Buy" from Analysts

Ambarella, Inc. (NASDAQ:AMBA) has received an average rating of "Moderate Buy" from analysts, with a consensus 12-month price target of $101.13. The semiconductor company reported quarterly revenue of $100.36 million, a 16.9% year-over-year increase, and earnings per share of $0.11, meeting estimates. However, the …

Relay Therapeutics, Inc. Stock 12‑Month Price Target Raised to $26.31, Implies 33% Upside

The average 12-month price target for Relay Therapeutics, Inc. (RLAY) stock has increased to $26.31 from $26.08, based on estimates from 13 analysts. This new target suggests a potential upside of approximately 33% from its Aug. 6 closing price. The consensus rating from 14 …

RELMADA THERAPEUTICS, INC. 2Q 2026: Net loss $12.9M, EPS $(0.11) — 10-Q Summary

RELMADA THERAPEUTICS, INC. reported a net loss of $12.9 million and a diluted loss per share of $0.11 for the second quarter of 2026. This widened loss compared to the previous year is attributed to increased R&D and manufacturing spending to advance its pipeline. …

Press Release: Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Relmada Therapeutics announced its second quarter 2026 financial results and provided a business update. The report details the company's financial performance during this period and outlines key developments in its business operations. This release offers stakeholders insight into Relmada's recent progress and future outlook.

Relmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ...

Relmada Therapeutics Inc (RLMD) reported strong Phase 2 data for NDVO1 and has FDA alignment on registrational pathways. Despite a strong balance sheet and plans for IND filings by the end of 2026, the company faces delays in NDVO1 IND filing due to manufacturing …

Stocks to watch: SBI, Titan, LIC, Reliance Power, Swan Defence & Britannia

Reliance (RS) Beats Earnings Expectations, Is The Stock Already Fully Valued?